immunate 250 iu fviii / 190 iu vwf vial i.v
اميونات 250/190وحدة دولية فيال
coagulation factor viii+von willebrand factorThe published official price. Pharmacies may differ slightly.
- Strength
- 250 iu + 190 iu
- Form
- vial
- Manufacturer
- baxter ag > takeda
- Route
- injection
The medical information below is guidance and may be incomplete or wrong. Do not change your medicine or dose based on it — ask a pharmacist or doctor.
Uses
Used for the treatment and prophylaxis of bleeding in patients with hemophilia A and von Willebrand disease. Replaces deficient or dysfunctional clotting factors to control hemorrhagic episodes.
Do not use if
Contraindicated in patients with known hypersensitivity to mouse or hamster proteins (if product is derived from cell cultures using these species). Contraindicated if patient has known hypersensitivity to any component.
Side effects
May cause allergic or anaphylactic reactions, fever, chills, and injection site reactions. Development of inhibitory antibodies (inhibitors) against factor VIII is a major complication in hemophilia A treatment.
Warnings
Monitor patients for development of factor VIII inhibitors, particularly during early treatment. Allergic reactions including anaphylaxis can occur; have epinephrine available. Use with caution in patients with cardiovascular risk factors due to potential thrombotic risk.
How it works
Coagulation factor VIII is an essential cofactor in the intrinsic coagulation pathway, required for the activation of factor X. Von Willebrand factor stabilizes factor VIII in plasma and mediates platelet adhesion to damaged vascular endothelium, facilitating primary hemostasis.
Storage
Store refrigerated at 2–8°C. Do not freeze. Protect from light. May be stored at room temperature (up to 25°C) for a limited period as specified in the product label.